Overall characteristics of 328 eligible patients, by induction treatment arm
| . | AD (n = 161) . | ME (n = 167) . | ||
|---|---|---|---|---|
| Median . | Range . | Median . | Range . | |
| Age, y | 68 | 56-84 | 67 | 56-86 |
| Marrow blasts, % | 60 | 6-99 | 61 | 5-99 |
| WBC count, × 1000/μL | 11.6 | 0.8-273 | 10.5 | 0.6-241 |
| Peripheral blasts, % | 22 | 0-99 | 27 | 0-99 |
| Peripheral blast count, × 1000/μL | 3.1 | 0-237 | 2.5 | 0-207 |
| Hemoglobin level, g/dL | 9.1 | 4.3-14.4 | 9.1 | 5.9-14.9 |
| Platelet count, × 1000/μL | 51.5 | 2-1200 | 55.0 | 3-690 |
| . | AD (n = 161) . | ME (n = 167) . | ||
|---|---|---|---|---|
| Median . | Range . | Median . | Range . | |
| Age, y | 68 | 56-84 | 67 | 56-86 |
| Marrow blasts, % | 60 | 6-99 | 61 | 5-99 |
| WBC count, × 1000/μL | 11.6 | 0.8-273 | 10.5 | 0.6-241 |
| Peripheral blasts, % | 22 | 0-99 | 27 | 0-99 |
| Peripheral blast count, × 1000/μL | 3.1 | 0-237 | 2.5 | 0-207 |
| Hemoglobin level, g/dL | 9.1 | 4.3-14.4 | 9.1 | 5.9-14.9 |
| Platelet count, × 1000/μL | 51.5 | 2-1200 | 55.0 | 3-690 |